Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 12, 2024 06:59 ET | Source: Sobi, Inc.

Sobi Announces FDA Acceptance of New Drug Application for Avatrombopag (DOPTELET®) for the Treatment of Pediatric Immune Thrombocytopenia

WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced that the U.S. Food and Drug Administration...
July 02, 2024 16:05 ET | Source: Gyre Therapeutics, Inc.

Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia

Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
November 06, 2023 13:07 ET | Source: Sobi, Inc.

Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia

Health Canada Approves DOPTELET (avatrombopag) for Two Indications in Thrombocytopenia